GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
about
Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with PrediabetesPrevalence of coronary artery calcification in Japanese patients with psoriasis: A close correlation with bilateral diagonal earlobe creases.Psoriasis as a human model of disease to study inflammatory atherogenesis.Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It Hot.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts.
P2860
Q33795043-A6EDEFE5-4717-4FD8-A7CD-5D46226F5A5BQ38808623-97939A95-4910-4E05-8BC5-EFED19C6C5F6Q39160397-04F20BF5-618A-4668-B0E7-AED8A700F48DQ39412708-3E5E9AFC-A14D-4754-88BF-AB877207F4ADQ40209798-C0569DD9-E28C-48F9-964F-81D349E9DEE0Q41628541-2134411F-00F1-4E63-A701-75D4D6A97CCBQ42617646-01C47759-9DA3-4F8C-87E4-AB9E02118825Q43288683-CF7D1236-08A5-4DCB-BBFC-D2CBE076887EQ46180528-E05B7421-EC0B-4768-9093-9A4426177173Q47218445-F14E4A9B-D615-4AE8-8706-3C0FB8562E41Q48266352-6B40A627-8D78-4BB3-8353-A1C96CD39653Q49792187-6BEDAB30-8FBF-4C62-B4D1-699C0974C420Q50154700-8ED6C968-69A5-4F08-B823-7942FFD8C087Q55420505-27595AD1-9078-4982-B956-DB7DBA087A3F
P2860
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
GlycA Is a Novel Biomarker of ...... vascular Disease in Psoriasis.
@en
type
label
GlycA Is a Novel Biomarker of ...... vascular Disease in Psoriasis.
@en
prefLabel
GlycA Is a Novel Biomarker of ...... vascular Disease in Psoriasis.
@en
P2093
P2860
P50
P1433
P1476
GlycA Is a Novel Biomarker of ...... ovascular Disease in Psoriasis
@en
P2093
Alan T Remaley
Balaji Natarajan
Benjamin N Lockshin
Daniel J Rader
Heather L Teague
Joseph B Lerman
Justin A Rodante
Marcus Y Chen
Mark A Ahlman
Martin P Playford
P2860
P304
P356
10.1161/CIRCRESAHA.116.309637
P577
2016-09-21T00:00:00Z